225 related articles for article (PubMed ID: 32393650)
1. Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis.
Otto C; Wengert O; Unterwalder N; Meisel C; Ruprecht K
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32393650
[TBL] [Abstract][Full Text] [Related]
2. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity.
Wengert O; Rothenfusser-Korber E; Vollrath B; Bohner G; Scheibe F; Otto C; Hofmann J; Angstwurm K; Ruprecht K
J Neurol Sci; 2013 Dec; 335(1-2):124-30. PubMed ID: 24071064
[TBL] [Abstract][Full Text] [Related]
3. Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction.
Vlad B; Neidhart S; Hilty M; Ziegler M; Jelcic I
Front Neurol; 2023; 14():1135392. PubMed ID: 37034091
[TBL] [Abstract][Full Text] [Related]
4. Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis.
Petereit HF; Reske D; Tumani H; Jarius S; Markus Leweke F; Woitalla D; Pfister HW; Rubbert A
J Neurol; 2010 Nov; 257(11):1855-63. PubMed ID: 20556411
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study.
Arun T; Pattison L; Palace J
Neurology; 2020 Jun; 94(24):e2545-e2554. PubMed ID: 32354749
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
[TBL] [Abstract][Full Text] [Related]
7. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis.
Schimmelpennink MC; Quanjel M; Vorselaars A; Wiertz I; Veltkamp M; Van Moorsel C; Grutters JC
Expert Rev Respir Med; 2020 Jul; 14(7):749-756. PubMed ID: 32248706
[TBL] [Abstract][Full Text] [Related]
8. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
Chazal T; Costopoulos M; Maillart E; Fleury C; Psimaras D; Legendre P; Pineton de Chambrun M; Haroche J; Lubetzki C; Amoura Z; Legarff-Tavernier M; Cohen Aubart F
Eur J Neurol; 2019 Oct; 26(10):1274-1280. PubMed ID: 31021023
[TBL] [Abstract][Full Text] [Related]
9. Soluble Interleukin-2 Receptor: A Potential Marker for Monitoring Disease Activity in IgG4-Related Disease.
Karim AF; Eurelings LEM; Bansie RD; van Hagen PM; van Laar JAM; Dik WA
Mediators Inflamm; 2018; 2018():6103064. PubMed ID: 29686532
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
[TBL] [Abstract][Full Text] [Related]
11. CSF-ACE activity in probable CNS neurosarcoidosis.
Tahmoush AJ; Amir MS; Connor WW; Farry JK; Didato S; Ulhoa-Cintra A; Vasas JM; Schwartzman RJ; Israel HL; Patrick H
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Oct; 19(3):191-7. PubMed ID: 12405488
[TBL] [Abstract][Full Text] [Related]
12. CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.
Ikeguchi R; Shimizu Y; Shimizu S; Kitagawa K
Mult Scler; 2018 Aug; 24(9):1212-1223. PubMed ID: 28657431
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid CD4
Nordström S; Andersson B; Malmeström C
Acta Neurol Scand; 2020 Nov; 142(5):480-485. PubMed ID: 32533774
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis.
Heming M; Lohmann L; Schulte-Mecklenbeck A; Brix T; Gross CC; Wiendl H; Klotz L; Meyer Zu Hörste G
J Neuroimmunol; 2020 Apr; 341():577171. PubMed ID: 32007787
[TBL] [Abstract][Full Text] [Related]
15. Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes.
Seidler S; Zimmermann HW; Weiskirchen R; Trautwein C; Tacke F
BMC Gastroenterol; 2012 Apr; 12():38. PubMed ID: 22530792
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome.
Bansil S; Mithen FA; Cook SD; Sheffet A; Rohowsky-Kochan C
Neurology; 1991 Aug; 41(8):1302-5. PubMed ID: 1866024
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme in cerebrospinal fluid: a new assay.
Oksanen V; Fyhrquist F; Somer H; Grönhagen-Riska C
Neurology; 1985 Aug; 35(8):1220-3. PubMed ID: 2991815
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid lysozyme and beta 2-microglobulin in neurosarcoidosis.
Oksanen V; Grönhagen-Riska C; Tikanoja S; Somer H; Fyhrquist F
J Neurol Sci; 1986 Mar; 73(1):79-87. PubMed ID: 3517236
[TBL] [Abstract][Full Text] [Related]
20. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
